Are you over 18 and want to see adult content?
More Annotations
A complete backup of modelsfashionpk.com
Are you over 18 and want to see adult content?
A complete backup of grillsportverein.de
Are you over 18 and want to see adult content?
A complete backup of restauraciondeclasicos.com
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://www.qingse.one/view/889.html
Are you over 18 and want to see adult content?
A complete backup of https://chinaq.tv/back-to-1989/
Are you over 18 and want to see adult content?
A complete backup of http://easysheetmusic.com/
Are you over 18 and want to see adult content?
A complete backup of https://v-s.mobi/candy-shop-10:13
Are you over 18 and want to see adult content?
A complete backup of https://www.au-e.com/site/khanekaram.com
Are you over 18 and want to see adult content?
A complete backup of https://www.qingse.one/view/3103.html
Are you over 18 and want to see adult content?
Text
HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
Amarin is a rapidly growing, innovative pharmaceutical company focused on commercializing and developing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one for SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo DIABETES & HEART DISEASE RISK VASCEPA is an FDA-approved, prescription medicine that can give your heart added protection when taken with a statin. VASCEPA can help manage your CV risk if you have diabetes or heart disease. That risk can be persistent and often elevated, especially since you may not realize just how at risk you may be. In a recent survey of people age45
OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
Amarin is a rapidly growing, innovative pharmaceutical company focused on commercializing and developing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one for SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo DIABETES & HEART DISEASE RISK VASCEPA is an FDA-approved, prescription medicine that can give your heart added protection when taken with a statin. VASCEPA can help manage your CV risk if you have diabetes or heart disease. That risk can be persistent and often elevated, especially since you may not realize just how at risk you may be. In a recent survey of people age45
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
How VASCEPA reduces CV risk. VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥ 150 mg/dL) and heart disease or diabetes with other CV risk factors. VASCEPA® SAVINGS PROGRAM With the VASCEPA® Savings Card, commercially insured patients may pay as little as $9 for 90 days*. Learn more about the VASCEPA® SavingsProgram. Please
SAFETY & SIDE EFFECTS This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS 25% added heart protection is possible? Really? Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380(1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
How VASCEPA reduces CV risk. VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥ 150 mg/dL) and heart disease or diabetes with other CV risk factors. VASCEPA® SAVINGS PROGRAM With the VASCEPA® Savings Card, commercially insured patients may pay as little as $9 for 90 days*. Learn more about the VASCEPA® SavingsProgram. Please
SAFETY & SIDE EFFECTS This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS 25% added heart protection is possible? Really? Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380(1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
HEALTHY HEART TIPS
Diet and exercise are a big part of managing cardiovascular (CV) risk, but simple lifestyle changes can make a difference too. Learn how you can add heart-healthy habits to your routine. Please see Indication and Important Safety Information. OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placeboWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placeboWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
HEALTHY HEART TIPS
Diet and exercise are a big part of managing cardiovascular (CV) risk, but simple lifestyle changes can make a difference too. Learn how you can add heart-healthy habits to your routine. Please see Indication and Important Safety Information. OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placeboWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other SIGN UP FOR SUPPORT & INFO This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placeboWWW.VASCEPA.COM
www.vascepa.com
CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
HEALTHY HEART TIPS
Diet and exercise are a big part of managing cardiovascular (CV) risk, but simple lifestyle changes can make a difference too. Learn how you can add heart-healthy habits to your routine. Please see Indication and Important Safety Information. OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. ABOUT VASCEPA® (ICOSAPENT ETHYL) This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) To ensure you get the full benefit of VASCEPA, it’s important to follow these dosing guidelines: For the standard size, take two 1-gram capsules twice a day with food. If you prefer the smaller size, take four of the 0.5-gram capsules twice a day with food. Swallow capsuleswhole. Do
SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
Amarin is a rapidly growing, innovative pharmaceutical company focused on commercializing and developing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one forWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
FDA-approved VASCEPA is made up of one active ingredient: icosapent ethyl (IPE), which is an innovative form of EPA. If “EPA” sounds familiar, that’s because it’s an omega-3 fatty acid. IPE is the only active ingredient in VASCEPA and is considered the reason behind the significant cardiovascular benefits VASCEPA can deliver. ABOUT VASCEPA® (ICOSAPENT ETHYL) This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other VASCEPA® SAVINGS PROGRAM Maximum savings of $150 per month or $450 per 90-day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2021. By texting VASCEPA to 26789, you consent to receive recurring automated text messages from us and our partners. DOSING | VASCEPA® (ICOSAPENT ETHYL) To ensure you get the full benefit of VASCEPA, it’s important to follow these dosing guidelines: For the standard size, take two 1-gram capsules twice a day with food. If you prefer the smaller size, take four of the 0.5-gram capsules twice a day with food. Swallow capsuleswhole. Do
SAFETY & SIDE EFFECTS In patients with risk factors for CV disease, serious side effects can include bleeding and heart rhythm problems that can cause hospitalization. Tell your doctor if you get any symptoms of joint pain, swelling of the hands, legs, or feet, constipation, gout, and irregular heartbeat. Symptoms of heart rhythm problems include feelingas if your
ABOUT AMARIN
Amarin is a rapidly growing, innovative pharmaceutical company focused on commercializing and developing therapeutics to cost-effectively improve cardiovascular health. Amarin’s lead product, VASCEPA, is a prescription drug. In the United States, VASCEPA is approved and marketed by Amarin’s commercial team for two indications: one forWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380 (1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
HEALTHY HEART TIPS
Diet and exercise are a big part of managing cardiovascular (CV) risk, but simple lifestyle changes can make a difference too. Learn how you can add heart-healthy habits to your routine. Please see Indication and Important Safety Information. OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
How VASCEPA reduces CV risk. VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥ 150 mg/dL) and heart disease or diabetes with other CV risk factors. ABOUT VASCEPA® (ICOSAPENT ETHYL) This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other VASCEPA® SAVINGS PROGRAM With the VASCEPA® Savings Card, commercially insured patients may pay as little as $9 for 90 days*. Learn more about the VASCEPA® SavingsProgram. Please
SAFETY & SIDE EFFECTS This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS 25% added heart protection is possible? Really? Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380(1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other OFFICIAL PATIENT SITE VASCEPA® (icosapent ethyl) is a prescription medication approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues. Please see Indication and Important Safety Information.HOW IT WORKS
How VASCEPA reduces CV risk. VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥ 150 mg/dL) and heart disease or diabetes with other CV risk factors. ABOUT VASCEPA® (ICOSAPENT ETHYL) This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other VASCEPA® SAVINGS PROGRAM With the VASCEPA® Savings Card, commercially insured patients may pay as little as $9 for 90 days*. Learn more about the VASCEPA® SavingsProgram. Please
SAFETY & SIDE EFFECTS This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other DOSING | VASCEPA® (ICOSAPENT ETHYL) The right dose makes a difference. In clinical testing conducted during the REDUCE-IT ® trial, patients took the FDA-approved 4-gram dose (four 1-gram capsules, or eight 0.5-gram capsules) each day to achieve 25% added heart protection on top of statins. Patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%).ABOUT AMARIN
This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
CLINICAL TRIAL RESULTS 25% added heart protection is possible? Really? Yes, really. A groundbreaking 2018 study † proved that VASCEPA lowers your chance of a life-threatening heart attack or stroke by 25% when added to a statin*. † REDUCE-IT ® study N Engl J Med. 2019;380(1):11-22. *In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or other CARDIOVASCULAR RISK QUIZ This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, VASCEPA ® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or otherWWW.VASCEPA.COM
www.vascepa.com
HEALTHY HEART TIPS
Diet and exercise are a big part of managing cardiovascular (CV) risk, but simple lifestyle changes can make a difference too. Learn how you can add heart-healthy habits to your routine. Please see Indication and Important Safety Information. tags on every page of your site. --> To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Video Player is loading.Play VideoPlay
Current Time 0:00
/
Duration 0:00
Loaded: 0%
0:00Progress: 0%
Mute
Fullscreen
This is a modal window. The media could not be loaded, either because the server or network failed or because the format is not supported. Beginning of dialog window. Escape will cancel and close the window. TextColorWhiteBlackRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentBackgroundColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyOpaqueSemi-TransparentTransparentWindowColorBlackWhiteRedGreenBlueYellowMagentaCyanTransparencyTransparentSemi-TransparentOpaque Font Size50%75%100%125%150%175%200%300%400%Text Edge StyleNoneRaisedDepressedUniformDropshadowFont FamilyProportional Sans-SerifMonospace Sans-SerifProportional SerifMonospace SerifCasualScriptSmall Caps Reset restore all settings to the default valuesDoneClose Modal Dialog End of dialog window.REGISTER NOW FOR
THE VASCEPA CLEAR PATH PROGRAM. ------------------------- SIGN UP BELOW TO LEARN MORE ABOUT VASCEPA, THE VASCEPA SAVINGS PROGRAM, AND TIPS ON MANAGING VERY HIGH TRIGLYCERIDE LEVELS. By registering at this site, you certify that you reside in the United States and are at least 18 years of age. Amarin Pharma, Inc. understands that your personal and health information is private. The information you provide will only be used by Amarin Pharma, Inc. and parties acting on its behalf to send you the materials you requested and other helpful information and updates on VASCEPA for very high triglyceride levels, as well as related information and services. We will protect your privacy in accordance with our privacy policy.
*Current therapy (select one) Not on therapy for very high triglycerides Taking fish-oil dietary supplements for very high triglycerides Taking a prescription drug for very high triglycerides Already taking or will be taking VASCEPA Other State (optional) Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin WyomingState (optional)
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of ColumbiaFlorida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
(*indicates required fields)Submit Now
THANK YOU FOR
REGISTERING FOR
THE VASCEPA
CLEAR PATH PROGRAM!
------------------------- Emails with useful info and Clear Path Tips will be arriving soon. Important Safety InformationFull Prescribing Information For Healthcare Professionals About AMARINSIGN UP About
VASCEPA WHAT ARE
TRIGLYCERIDES VASCEPADIFFERENCE VASCEPA
SCIENCE SAVINGS &
RESOURCES SIGN UP
A NEW FDA-APPROVED INDICATION VASCEPA® is now approved, along with certain medicines (statins), to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heartdisease.
REGISTER NOW FOR
THE VASCEPA CLEAR PATH PROGRAM. ------------------------- SIGN UP BELOW TO LEARN MORE ABOUT VASCEPA, THE VASCEPA SAVINGS PROGRAM, AND TIPS ON MANAGING VERY HIGH TRIGLYCERIDE LEVELS. By registering at this site, you certify that you reside in the United States and are at least 18 years of age. Amarin Pharma, Inc. understands that your personal and health information is private. The information you provide will only be used by Amarin Pharma, Inc. and parties acting on its behalf to send you the materials you requested and other helpful information and updates on VASCEPA for very high triglyceride levels, as well as related information and services. We will protect your privacy in accordance with our privacy policy.
*Current therapy (select one) Not on therapy for very high triglycerides Taking fish-oil dietary supplements for very high triglycerides Taking a prescription drug for very high triglycerides Already taking or will be taking VASCEPA Other State (optional) Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District Of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin WyomingState (optional)
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District Of ColumbiaFlorida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
(*indicates required fields)Submit Now
THANK YOU FOR
REGISTERING FOR
THE VASCEPA
CLEAR PATH PROGRAM!
------------------------- Emails with useful info and Clear Path Tips will be arriving soon. YOU ARE LEAVING VASCEPA.COM You are now leaving vascepa.com to view an external website that is not managed by Amarin Pharma, Inc.CANCEL
PROCEED
READ PRESS RELEASE
READ FDA APPROVAL
DISCOVER VASCEPA.
PURE. PROVEN. PRESCRIPTION. WATCH OUR TV COMMERCIAL SAVE NOW VIA TEXT Pay as little as $9 for 90 days*X
Thank you for
your submission Message & data rates may apply. Message frequencyvaries.
Once enrolled, text HELP for info, STOP to opt out. Prescription VASCEPA VASCEPA (VAS-EE-PUH), ALONG WITH DIET, IS CLINICALLY PROVEN TO LOWER VERY HIGH TRIGLYCERIDES IN ADULTS BY WITHOUT RAISING BAD CHOLESTEROL (LDL-C).†* ------------------------- PRESCRIPTION VASCEPA IS FDA-APPROVED AND HAS A SAFETY PROFILE SIMILARTO PLACEBO.
†*In MARINE trial, on average, along with diet changes, adults with very high triglycerides experienced a 33% reduction without raising LDL-C vs. placebo. Individual results may vary. PRESCRIPTION VASCEPA. ------------------------- VASCEPA follows strict prescription medication regulatory, consistency and purity standards. VASCEPA doesn't contain potentially harmful or unwanted components, impurities or saturated fats. VASCEPA IS DIFFERENT THAN OTHER PRESCRIPTION MEDICATIONS. ------------------------- Earlier generation, FDA-approved treatment options for very high triglycerides are associated with potential unwanted side effects, including muscle pain and a significant increase in bad cholesterol(LDL-C).
THERE'S ONLY ONE VASCEPA. VASCEPA is the first and only prescription EPA treatment approved by the FDA to lower very high triglycerides (without raising bad cholesterol). And has a safety profile similar to placebo.SIGN UP.
------------------------- Sign up for the VASCEPA Clear Path Support Program. Recipes, exercises and the latest VASCEPA monthly news - just for you.REGISTER TODAY
SAVE NOW.
------------------------- Save on a prescription now. Commercially insured patients canpay as little as $9
for 90 days.*
Subject to eligibility. Restrictions apply.GET SAVINGS CARD
Thank you for
your submission X
Save on VASCEPA
Register for the VASCEPA Savings Program by entering your mobile number below or textingVASCEPA to 26789
Message & data rates may apply. Message frequency varies. Once registered, text HELP for more info. Text STOP to end.ABOUT YOUR PRIVACY
TERMS AND CONDITIONS GET HELPFUL QUESTIONS. ------------------------- Get helpful questions to ask your doctor. Talking points right at yourfingertips.
DOWNLOAD YOUR GUIDE NOW *†May not be used to obtain prescription drugs paid for in part by Federal or State Healthcare Programs including Medicare, Medicaid, Medicare Advantage, Medicare Part D, Tricare, and VA. Not for use by VT residents, VT licensed medical professionals, patients under 18, where prohibited by law or patient's insurance plan, or where taxed or restricted. Maximum savings of $150 per month or $450 per 90 day supply. Eligible patients include those who participate in commercial insurance, through a healthcare exchange, or pay cash. Offer good through December 31, 2020. This site uses cookies to give you the best possible experience. By browsing our website, you agree to our use of cookies. If you require further information and/or do not wish to have cookies placed when using the site, visit the Privacy Policypage.
INDICATION AND IMPORTANT SAFETY INFORMATIONWHAT IS VASCEPA?
VASCEPA is a prescription medicine used: * along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with heart (cardiovascular) disease, or diabetes and 2 or more additional risk factors for heart disease. * along with a low-fat and low-cholesterol diet to lower high levels of triglycerides (fats) in adults. It is not known if VASCEPA changes your risk of having inflammation of your pancreas (pancreatitis). It is not known if VASCEPA is safe and effective in children. IMPORTANT SAFETY INFORMATION WHO SHOULD NOT TAKE VASCEPA? * Do not take VASCEPA if you are allergic to icosapent ethyl or any of the ingredients in VASCEPA. WHAT ARE THE POSSIBLE SIDE EFFECTS OF VASCEPA? VASCEPA MAY CAUSE SERIOUS SIDE EFFECTS, INCLUDING: * HEART RHYTHM PROBLEMS (ATRIAL FIBRILLATION AND ATRIAL FLUTTER). Heart rhythm problems which can be serious and cause hospitalization have happened in people who take VASCEPA, especially in people who have heart (cardiovascular) disease or diabetes with a risk factor for heart (cardiovascular) disease, or who have had heart rhythm problems in the past. Tell your doctor if you get any symptoms of heart rhythm problems such as feeling as if your heart is beating fast and irregular, lightheadedness, dizziness, shortness of breath, chest discomfort or you faint. * POSSIBLE ALLERGIC REACTIONS IF YOU ARE ALLERGIC TO FISH OR SHELLFISH. Stop taking VASCEPA and tell your doctor right away or get emergency medical help if you have any signs or symptoms of anallergic reaction.
* BLEEDING. Serious bleeding can happen in people who take VASCEPA. Your risk of bleeding may increase if you are also taking a blood thinner medicine. If you have liver problems and are taking VASCEPA, your doctor should do blood tests during treatment. The most common side effects of VASCEPA include: * Muscle and joint pain * Swelling of the hands, legs, or feet* Constipation
* Gout
* Heart rhythm problems (atrial fibrillation) These are not all the possible side effects of VASCEPA. Call your doctor for medical advice about side effects. You may report adverse events (i.e. side effects) or product complaints by calling 1-855-VASCEPA (1-855-827-2372), emailing AmarinMI@druginfo.com, or calling the FDA at 1-800-FDA-1088. Tell your doctor if you take medicines that affect your blood clotting (anticoagulants or blood thinners). For more information on VASCEPA, click hereto see the full
Patient Information or call 1-855-VASCEPA (1-855-827-2372).Privacy Policy
|Contact Us
|Full Prescribing
Information
|Important Safety
Information
Trademarks are owned by their respective companies; VASCEPA, Amarin, and VASCEPA/Amarin logos are registered trademarks of the Amarin groupof companies.
2020 Amarin Pharma, Inc. Bridgewater, NJ, USA. All rights reserved. VAS-01935v6 04/2020 ------------------------- This website, vascepa.com, vascepahcp.com, vascepasavings.com, truetoyourheart.com, and the corporation's website (amarincorp.com), are the only company-sanctioned websites pertaining to the Amarin group of companies or its product, Vascepa® (icosapent ethyl) capsules. The Amarin group of companies is not responsible for material contained on other non-Amarin controlled websites or othersocial media sites.
Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0